Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study

Buprenorphine, a partial mu-opioid agonist and kappa-opioid antagonist, is an approved treatment for opioid use disorder (OUD). Studies demonstrate that buprenorphine decreases cravings for other opioids, effectively ameliorates withdrawal symptoms, and decreases opioid overdose and mortality. Howev...

Ausführliche Beschreibung